VMI
ISEE

VHCP Management III’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

VHCP Management III’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$14.6M Buy
+1,699,797
New +$6.07M 2.9% 9

Other funds holding ISEE

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Burrage Capital Management Boston, Massachusetts $99.7M AUM 66.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

VHCP Management III's ISEE Position: Q4 2019 in Review

VHCP Management III opened a new position in IVERIC bio, Inc. Common Stock (ISEE) in Q4 2019: 1,699,797 shares worth $14.6M. The stake represents 2.9% of the portfolio and ranks #9 among its holdings.

68 funds tracked by Wall St. Rank hold ISEE as of Q4 2019.

  • VHCP Management III held 1,699,797 shares of IVERIC bio, Inc. Common Stock worth $14.6M as of Q4 2019.
  • IVERIC bio, Inc. Common Stock was a new VHCP Management III position in Q4 2019.
  • IVERIC bio, Inc. Common Stock made up 2.9% of VHCP Management III's portfolio in Q4 2019, its #9 holding.
  • 68 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2019.

Based on VHCP Management III's 13F filing for Q4 2019, filed 13 Feb 2020.